ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy

TitleABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy
Publication TypeJournal Article
Year of Publication2007
AuthorsWorel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A, Hocker P, Kalhs P
JournalTransfus Apher Sci
Volume36
Issue3
Pagination297 - 304
Date PublishedJun
ISSN1473-0502 (Print) 1473-0502 (Linking)
Accession Number17569587
KeywordsABO Blood-Group System / *immunology, Adolescent, Adult, Aged, Blood Group Incompatibility / *complications, Female, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation / *adverse effects / methods, Humans, Male, Microcirculation, Microvessels / pathology, Middle Aged, Peripheral Vascular Diseases / *etiology / therapy, Plasma Exchange, Risk Factors, Transplantation Conditioning / *methods, Transplantation, Homologous, Treatment Outcome, Young Adult
Abstract

Transplant-associated microangiopathy (TAM) is a severe complication following allogeneic hematopoietic stem cell transplantation (HSCT) even after reduced-intensity conditioning (RIC). Data on 112 patients following RIC were analyzed with respect to TAM according to the ASBMT and risk factors, response to well-defined therapy and outcome were determined. TAM occurred in 11 of 112 patients. Univariate analysis determined acute graft-versus-host disease and ABO-incompatibility as risk factors for TAM. Treatment consisted of withdrawal of calcineurin inhibitors and plasma exchange (PE). Response to PE was 64%. PE seems to be an effective therapeutic option that should be assessed in larger patient cohorts.

DOI10.1016/j.transci.2007.03.004
Notify Library Reference ID1655

Related Incidents